Home | Contact Us | Search | Site Map
Crucell
Development Programs




Valuable product pipeline

Crucell currently has vaccine and protein programs in various stages of development. Most of these are based on Crucell’s innovative PER.C6® production technology. Core programs include vaccines against the Ebola virus, influenza, malaria and West Nile virus, as well as a rabies antibody product.

 

Crucell’s current pipeline programs comprise:

 

 

 

 

 

 

 

 

Vaccines

PC

Phase

License

   

I

II

III

 

Yellow Fever

   

 

Malaria

 

 

 

 

Tuberculosis1

     

 

Ebola2

 

HIV3

 

 

 

 

Influenza seasonal4

 

 

 

 

Influenza pandemic

  • H9N2

  • H7N1/FLUPAN5


Proteins

PC

Phase

Filing

Expected
Launch

   

I

II

III

   

Rabies antibody cocktail

    

 

 

 

 

Anti-bacterial antibodies6

 

 

1 Partnered with Aeras Foundation

2 Partnered with VRC

3 Partnered with Harvard

4 Partnered with sanofi pasteur

5 Developed by sanofi pasteur, technology supplied by Crucell

6 Partnered with MedImmune

 

Information updated October 2007

Served by MoveNext © Crucell 2006 | Disclaimer